Given the heterogeneity of the tumor stroma, it will be critical to understand the inter-relationship between stroma, neoplastic cells, and immune cells, which is significant for selection of immunotherapies (e.g., PDL and PDL1 blockade treatment) in patients with HCC. This evidence concerns the gene CD274 and neoplasm.